Skip to content
Krypton AI
Client portal
Demo

Book 30 minutes with us.

We prepare a first read on your company: your story, the funds that own your peers, and a short briefing. A person reviews it before we meet.

Prefer email? contact@kryptonai.io

Magnera Corporation

Ticker
MAGN
Sector
Specialty materials
Dated
28 September 2026
Stance
BUY (initiated)

Priced as an over-levered spin-off at 5.5x trailing EBITDA. Half the merger savings are banked, and $90M to $110M of free cash flow is going to debt, moving value to shareholders.

Price (29 Sep 26)
$11.63
Price target (12m)
$15.40
Scenario value*
$15.42
Bear / Base / Bull
$4.55 / $15.44 / $26.23
Market cap
$416.4M
Enterprise value
$2,037.4M
Free float
98.9% of S/O
Avg daily vol, 3m
420k / $5.3M
Short interest
5.6% float, -2.6pt
Institutional own.
102.8%, +2.9pt
Largest holder
Newtyn Management, 7.8%
Insider and board
1.1%

*Probability-weighted, 25/50/25, over 12 months. Price target is the base case, rounded to the nearest ten cents.

The thesis

  1. Most of the merger savings are already banked. Synergies still to come fell from $68M in November 2025 to $35M by 6 August 2026, and our base case credits less than half of what remains.
  2. The last piece of the separation still runs on Berry's systems. Moving off the transition services agreement removes a cost line and a control deficiency named in the 6 August 2026 10-Q.
  3. The cash flow pays the debt down. Fiscal 2026 free cash flow guidance of $90M to $110M is about a quarter of the $416M market value, and $100M of repayment adds about $2.80 a share at an unchanged enterprise value.
  4. The Americas already pass costs through and the Rest of World is catching up. Americas margins were 14.9% in the June quarter against 7.3% abroad, and each point of Rest of World margin is about $15M of EBITDA.

Read the whole thing

The business, the market, the financials, the valuation with its scenarios, the risks and the catalysts. A PDF of 5 pages, 585 KB, sent to you, free.

Magnera Corporation

The full report, free. We send it as a PDF attachment, and we use the address for new research and nothing else.

Independent research. This is not investment advice and is not a recommendation to buy or sell any security. Please consult an accredited financial adviser before making any decision.

Comments

No comments yet.

Comments are read before they appear.